Identifying Kinase Inhibitors as Potential Adjuvant Chemotherapeutics in Treatment for Ovarian Cancer

被引:0
|
作者
Anliker, Clair [1 ]
Corradi, Anna [1 ]
Wallert, Mark [1 ]
机构
[1] Bemidji State Univ, Bemidji, MN USA
来源
FASEB JOURNAL | 2020年 / 34卷
关键词
D O I
10.1096/fasebj.2020.34.s1.06095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Investigating the Potential of NHE1 Inhibitors as Potential Adjuvant Therapies in the Treatment of Ovarian Cancer
    Corradi, Anna
    Wallert, Mark
    FASEB JOURNAL, 2020, 34
  • [2] The potential of farnesyltransferase inhibitors as cancer chemotherapeutics
    Gibbs, JB
    Oliff, A
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 : 143 - 166
  • [3] Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity—a perspective overview
    Emma Baglini
    Lorenzo Chiaverini
    Iogann Tolbatov
    Sabrina Taliani
    Federico Da Settimo
    Diego La Mendola
    Elisabetta Barresi
    Tiziano Marzo
    BioMetals, 2024, 37 : 275 - 288
  • [4] Investigating the Potential for NHE1 Inhibitors to Function as Adjuvant Therapies in the Treatment of Ovarian Cancer
    Corradi, Anna
    Wallert, Mark
    FASEB JOURNAL, 2021, 35
  • [5] Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview
    Baglini, Emma
    Chiaverini, Lorenzo
    Tolbatov, Iogann
    Taliani, Sabrina
    Da Settimo, Federico
    La Mendola, Diego
    Barresi, Elisabetta
    Marzo, Tiziano
    BIOMETALS, 2024, 37 (02) : 275 - 288
  • [6] Kinase Inhibitors and Ovarian Cancer
    Katopodis, Periklis
    Chudasama, Dimple
    Wander, Gurleen
    Sales, Louise
    Kumar, Juhi
    Pandhal, Manreen
    Anikin, Vladimir
    Chatterjee, Jayanta
    Hall, Marcia
    Karteris, Emmanouil
    CANCERS, 2019, 11 (09)
  • [7] Investigating the Role of Inhibitors of NHE1 Activation as Potential Adjuvant Therapies in the Treatment of Ovarian Cancer
    Corradi, Anna R.
    Wallert, Mark A.
    FASEB JOURNAL, 2019, 33
  • [8] The potential of MAO inhibitors as chemotherapeutics in cancer: A literature survey
    Sblano, Sabina
    Boccarelli, Angelina
    Deruvo, Caterina
    La Spada, Gabriella
    de Candia, Modesto
    Purgatorio, Rosa
    Altomare, Cosimo Damiano
    Catto, Marco
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 283
  • [9] AURORA A KINASE INHIBITORS AS A NEW APPROACH OF OVARIAN CANCER TREATMENT
    Bukowska, Barbara
    Marczak, Agnieszka
    POSTEPY BIOLOGII KOMORKI, 2015, 42 (04) : 633 - 643
  • [10] An overviewof tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer
    Wang, Zhijie
    Fu, Siqing
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (01) : 15 - 30